Cargando…
Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway
The failure of lung cancer treatments has been attributed mostly to the development of drug resistance, however the underlying cellular and molecular mechanisms are poorly understood. Cancer initiating stem cells (CSCs), present in tumors in a small percentage, play critical roles in the development...
Autores principales: | Green, Ryan, Howell, Mark, Khalil, Roukiah, Nair, Rajesh, Yan, Jiyu, Foran, Elspeth, Katiri, Sandhyabanu, Banerjee, Jit, Singh, Mandip, Bharadwaj, Srinivas, Mohapatra, Shyam S., Mohapatra, Subhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890794/ https://www.ncbi.nlm.nih.gov/pubmed/31796785 http://dx.doi.org/10.1038/s41598-019-54266-z |
Ejemplares similares
-
Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis
por: Howell, Mark C., et al.
Publicado: (2019) -
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021) -
Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells
por: Quarni, Waise, et al.
Publicado: (2019) -
Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer
por: Khalil, Roukiah, et al.
Publicado: (2023) -
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
por: Green, Ryan, et al.
Publicado: (2022)